Showing results (311-320 of 439) with videos related to
Sort By:
Pageof 44
Clinical Lymphoma, Myeloma & Leukemia|September 13, 2025
Clinical Outcomes and Patterns of Care Among Patients With Newly Diagnosed Classical Hodgkin Lymphoma in a Safety-Net Health SystemTrung Minh Nguyen, Jason Lu, Danielle Guffey, et al.American Journal of Hematology|September 20, 2018
The association of physical activity before and after lymphoma diagnosis with survival outcomesPriyanka A Pophali, Andrew Ip, Melissa C Larson, et al.Blood Advances|July 11, 2024
Evaluating the impact of laboratory-based eligibility criteria by race/ethnicity in first-line clinical trials of DLBCLArushi Khurana, Raphael Mwangi, Loretta J Nastoupil, et al.Nature Communications|August 7, 2025
Frontline acalabrutinib, lenalidomide and rituximab for advanced stage follicular lymphoma with high tumor burden: phase II trialPaolo Strati, Lei Feng, Jason R Westin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2015
Phase II Intergroup Trial of Alisertib in Relapsed and Refractory Peripheral T-Cell Lymphoma and Transformed Mycosis Fungoides: SWOG 1108Paul M Barr, Hongli Li, Catherine Spier, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 31, 2018
Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: a phase Ib dose-finding studyS de Vos, L J Swinnen, D Wang, et al.Blood Advances|January 11, 2022
Day 30 SUVmax predicts progression in patients with lymphoma achieving PR/SD after CAR T-cell therapyAjlan Al Zaki, Lei Feng, Grace Watson, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 7, 2014
Peripheral T-cell lymphomas in a large US multicenter cohort: prognostication in the modern era including impact of frontline therapyJ S Abramson, T Feldman, A R Kroll-Desrosiers, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 9, 2012
Examination of the follicular lymphoma international prognostic index (FLIPI) in the National LymphoCare study (NLCS): a prospective US patient cohort treated predominantly in community practicesA K Nooka, C Nabhan, X Zhou, et al.Leukemia & Lymphoma|July 18, 2012
Examining racial differences in diffuse large B-cell lymphoma presentation and survivalChristopher R Flowers, Pareen J Shenoy, Uma Borate, et al.Pageof 44